Balchem Corporation to Present at the Stephens Food & Ag Disrupted: Public-Private Conference May 25, 2021

NEW HAMPTON, N.Y., May 18, 2021 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at the Stephens Food & Ag Disrupted: Public-Private Conference on May 25, 2021. Balchem’s presentation will begin at 9:00 a.m. (ET).

Follow the below link to listen to this presentation
https://kvgo.com/stephens-food-ag/balchem-corp-may-2021

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Contact: Danielle Polanco, Executive and HR Assistant
  Telephone: 845-326-5600
  E-mail: [email protected]



OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference

BETHLEHEM, Pa., May 18, 2021 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the UBS Global Healthcare Virtual Conference. The conference will be simultaneously webcast over the Internet.

Dr. Tang is scheduled to speak on May 26, 2021, at 2:00 PM EDT. The live webcast and a replay of the presentation can be accessed by going to OraSure Technologies’ web site, www.orasure.com and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies’ web site for 14 days. Alternatively, you can access the live webcast of the presentation here.

About OraSure Technologies

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.

Company contacts:

Scott Gleason
SVP of IR and Corp. Communications
484-425-0588
[email protected]

Jeanne Mell
VP Corporate Communications
484-353-1575
[email protected]
www.orasure.com



New Inmar Intelligence Survey Shows 68 Percent of U.S. Shoppers Are Switching Store Loyalty To Save Money As Grocery Prices Increase

86 percent of shoppers are turning to store brand products to get the best deal, stressing the importance of value for retailers

Winston-Salem, NC, May 18, 2021 (GLOBE NEWSWIRE) — Inmar Intelligence, a data-driven, technology-enabled services company, today released findings from a new survey of 1,000 U.S. adults, which shows that 89 percent of shoppers have noticed an increase in prices of groceries and everyday household items that they regularly purchase, and 68 percent have gone so far as to shop at a different store for these items because of this price jump. 

According to recent figures from The Consumer Price Index, ‘all items’ have increased 4.2 percent over the last 12 months – the largest 12-month increase since September 2008. Additionally, the food index increased by 0.4 percent in April for both home-cooked meals and dining out. Today’s consumers are eager to get out of the house for their shopping, whether this is due to the increase in vaccinations or lessening of business restrictions, but they are still searching for value. While half (51 percent) of shoppers understand these are tough times and rising prices are a reflection of challenges faced, 41 percent believe that brands and retailers should find solutions to prevent rising prices for consumers. If not, they’ll have no problem switching stores to save money, as indicated above. 

Store brand products have also become a staple in consumers’ shopping carts. Eighty-six percent of shoppers purchase these store-brand products to save money. Beyond this, shoppers are eagerly joining loyalty programs and considering joining wholesale discount clubs to get the best deal out there. Fifty-two percent of shoppers have joined more than one loyalty program offered by grocery stores due to rising prices and 52 percent of shoppers are considering joining a wholesale discount club to save money on purchases. 

“The rising cost of groceries in the U.S. has certainly not gone unnoticed by today’s consumers,” said Spencer Baird, EVP and President of Inmar Intelligence’s MarTech division. “Shoppers are returning to physical stores and restaurants – but at the same time, still recovering from a global pandemic and expect to get value from their shopping experiences. The survey findings show just how quickly a consumer will change shopping habits in the name of cost savings. This should be a wake-up call for retailers, who must work to provide a seamless omnichannel experience with personalized promotions and coupons, to maintain and strengthen that customer relationship.” 

For decades, Inmar Intelligence has played a critical role in helping retailers make business decisions. Inmar Intelligence works to support retailers’ development and execution of an omnichannel shopping experience to meet rising consumer demand for personalization. While the pandemic accelerated the evolution of consumer buying behavior and trends, leaving some businesses flat-footed, Inmar Intelligence’s platform is able to meet these changing demands. With a technology infrastructure designed to execute machine learning and artificial intelligence at scale, Inmar Intelligence generates actionable insights to better inform planning decisions.

For more information about Inmar Intelligence, please visit https://www.inmar.com.

About Inmar Intelligence

Commerce Accelerated.™ 

Inmar Intelligence is a leading data and tech-enabled services company. $120 billion dollars of commerce runs through our market-driven platforms which are propelling digital transformation through unified data and workflows to help leading Fortune 5000 companies, emerging brands and health systems drive innovation.

Throughout our 40-year history, we have served retailers, manufacturers, pharmacies, health systems, government and employers as their trusted intermediary in helping them redefine success. For more information about Inmar, please follow us on Twitter, LinkedIn or Facebook, or call (866) 440-6917.



Holly Pavlika
Inmar Intelligence
(336) 770-3596
[email protected]

The Glimpse Group Establishes an Independent Board of Directors with the Appointment of Lemuel Amen as Director

NEW YORK, NY, May 18, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — The Glimpse Group, Inc. (“Glimpse”), a Virtual Reality and Augmented Reality (“VR” and “AR”) platform company comprised of multiple VR and AR software & services companies, announced today that its Board of Directors (“Board”) has appointed Lemuel Amen to its Board. Glimpse’s Board now numbers five directors, including three independent directors.

Mr. Lemuel Amen is the Founder and Chairman of Altius Manufacturing Group, LLC., an equity growth management firm. He has also held senior executive positions and led global business units for Electronic Data Systems (EDS) and 3M. Additionally, Mr. Amen is an experienced board member, serving high-growth technology, industrial services, application software firms and academic institutions. In addition, he served as Chairman for the Federal Reserve Bank of Minneapolis, Ninth District Advisory Council.  Mr. Amen earned his M.S. in Civil and Environmental Engineering from Northwestern University, and his B.S. in Mechanical Engineering at California State University-Northridge.

Lyron Bentovim, President & CEO of Glimpse, said, “We welcome Lem Amen as the third independent director of Glimpse. Lem is a world-class operator, a hands-on investor, and an experienced director. His operating expertise and business insights are of increasing importance as we continue to grow our platform of leading-edge VR and AR companies, which offer enterprise-class solutions to organizations across industries.”

Lem Amen added, “Glimpse’s subsidiary companies and immersive technologies are full of potential. With the accelerating adoption of these technologies in the enterprise, industrial and academic segments, I am excited to join Glimpse’s Board, and leverage my experience and knowledge in helping Glimpse strengthen its operating and governance infrastructures.”

About The Glimpse Group, Inc.

The Glimpse Group is a Virtual and Augmented Reality platform company, comprised of multiple VR and AR software & services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry. Glimpse’s unique business model simplifies challenges faced by VR/AR companies and creates a robust ecosystem, while simultaneously providing investors an opportunity to invest directly into the emerging VR/AR industry via a diversified platform. For more information on The Glimpse Group, please visit www.theglimpsegroup.com

Safe Harbor Statement 

This press release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity. This press release contains certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. Forward-looking statements in this release are based on information available to us as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business. Forward-looking statements include statements regarding our expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” and “would” or similar words. All forecasts are provided by management in this release are based on information available at this time and management expects that internal projections and expectations may change over time. In addition, the forecasts are entirely on management’s best estimate of our future financial performance given our current contracts, current backlog of opportunities and conversations with new and existing customers about our products and services. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise.  

Company Contact:

Maydan Rothblum
CFO & COO
The Glimpse Group, Inc.
(917) 292-2685
[email protected]



Calibre Mining Strengthens Management Team With Key Appointments

VANCOUVER, British Columbia, May 18, 2021 (GLOBE NEWSWIRE) — Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the “Company” or “Calibre”) is pleased to announce the addition of new senior management, including our new Vice President of Sustainability – Petri Salopera; Senior Manager of Regional Exploration – Greg Myers; and Ground Transportation Manager – Rigoberto Anaya.

Darren Hall, President and Chief Executive Officer of Calibre stated: “Over the past 12 months we have significantly strengthened our in-country management and operating team as we responsibly execute our business strategy. Today, I am pleased to welcome Petri Salopera, Greg Myers and Rigoberto Anaya to the Calibre team. Petri has extensive Latin America experience in community relations, environment, and sustainability, which will be invaluable as we expand our footprint and work towards conforming to the World Gold Council responsible mining principles. Greg brings significant in-country geological experience to support our exploration team and advance our robust pipeline of exploration opportunities along the prolific multi-million-ounce western epithermal gold belt. As Calibre continues to advance organic growth opportunities like the Eastern Borosi Project, which we expect will be our next ‘mining spoke’, Rigoberto’s experience in overseeing large transport fleets will be a welcomed addition to the team. I look forward to all their contributions in the months and years ahead.”

Vice President Sustainability

Mr. Petri Salopera

Petri has held senior executive positions at Goldcorp, Rio Tinto, BHP and most recently as Country Manager – Ecuador and Chile for Newcrest Mining. He brings extensive field experience in Latin America on community relations, environment, sustainability, government relations and media. His wide range of expertise also includes other private sector entities, academia, and non-governmental organizations. Petri obtained a Masters in Anthropology, Development and Latin American Studies from the University of Helsinki, Finland, and other postgraduate studies from the Sustainable Minerals Institute, University of Queensland, Australia.

Senior Manager of Generative Exploration

Dr. Greg Myers

Greg is an accomplished exploration and mine geologist with over 30 years of international experience. He has led several successful exploration programs, discovering significant resources at five gold and gold/copper deposits while working for Newmont Mining, Westmont Mining, Phelps Dodge, BHP Billiton, and Zacoro Metals. Greg led the exploration efforts of Caza Gold in Nicaragua and brings several years of Nicaraguan experience to Calibre.

Manager of Ground Transport

Mr. Rigoberto Anaya

Mr. Anaya brings significant experience in transport and logistics, strategic planning, and shipment scheduling within the mining sector. Mr. Anaya was recently Operations and Route Control Coordinator for the large +600-unit fleet of transport vehicles hauling ore concentrate from the Penasquito gold mine in Mexico. Mr. Anaya will focus on safety, streamlining fleet transport, and movement of ore in support of Calibre’s “hub-and-spoke” operating strategy.

In addition to the above key appointments, Calibre is pleased to announce Mr. Ryan King has been elevated to the position of Senior Vice President of Corporate Development and Investor Relations and Mr. Paulo Santos has been promoted to the position of Vice President of Finance.

Darren Hall, President and Chief Executive Officer of Calibre stated: “Ryan and Paulo bring extensive experience and knowledge into their new roles at Calibre and they are both integrally familiar with our business strategy and operations. I am confident that Ryan and Paulo will continue their diligent work, leadership, and management in all aspects of the Company’s business.”

Senior Vice President of Corporate Development and Investor Relations

Mr. Ryan King

Ryan brings a diligent and efficient approach to business in the natural resource sector and has a solid track record of delivering shareholder value in the mining industry. Ryan has been involved with Calibre as a consultant and/or officer since 2009 and since acquiring the Limon and Libertad operations from B2Gold, he has been the Company’s Vice President Corporate Development & Investor Relations. Ryan has over 16 years of experience in increasingly senior capacities in capital markets and corporate development in the resource sector and was responsible for leading the investor relations activities for Newmarket Gold and then Kirkland Lake Gold post the $2 billion merger in 2016.

Vice President of Finance

Mr. Paulo Santos

Paulo is a Chartered Professional Accountant with over 20 years in accounting, financial management, reporting and corporate governance, experienced in treasury management and merger and acquisitions. Since July 2019, Paulo has acted as the Company’s corporate controller. Immediately prior to joining Calibre, Paulo was the Chief Financial Officer at Northern Empire Resources Corp., which was acquired by Coeur Mining for $117 million in 2018. Before joining Northern Empire, he was the Treasurer and Corporate Secretary at Newmarket Gold Inc., a TSX-listed mid-tier Australian gold producer which produced over 220,000 ounces of gold annually. Paulo was a key member of the team that completed the successful merger between Newmarket Gold and Kirkland Lake Gold in November 2016.

ON BEHALF OF THE BOARD

“Darren Hall”

Darren Hall, President and Chief Executive Officer

For further information, please contact:

Ryan King

Senior Vice President Corporate Development and Investor Relations
Calibre Mining Corp.
T: 604.628.1012
E: [email protected]
W: www.calibremining.com


About Calibre Mining Corp.

Calibre Mining is a Canadian-listed gold mining and exploration company with two 100%-owned operating gold mines in Nicaragua. The Company is focused on sustainable operating performance and a disciplined approach to growth. Since the acquisition of the Limon, Libertad gold mines and Pavon Gold Project, Calibre has proceeded to integrate its operations into a “Hub-and-Spoke” operating philosophy, whereby the Company can take advantage of reliable infrastructure, favorable transportation costs, and multiple high-grade mill feed sources that can be processed at either Limon or Libertad, which have a combined 2.7 million tonnes of annual mill throughput capacity.



Interstate Power and Light Company declares preferred stock dividend

CEDAR RAPIDS, Iowa, May 18, 2021 (GLOBE NEWSWIRE) — The Board of Directors of Alliant Energy‘s Iowa utility, Interstate Power and Light Company (IPL), has declared dividends for its preferred stock (NASDAQ: IPLDP) shareowners of record on May 28, 2021. The dividends, which are payable on June 15, 2021, are as follows:

$0.31875 per share on the 5.1% Series D Cumulative Preferred Stock

Alliant Energy Corporation (NASDAQ: LNT) provides regulated energy service to 975,000 electric and 420,000 natural gas customers across Iowa and Wisconsin. Alliant Energy’s mission is to deliver the energy solutions and exceptional service customers and communities count on – safely, efficiently and responsibly. Interstate Power and Light Company and Wisconsin Power and Light Company are Alliant Energy’s two public utility subsidiaries.   Alliant Energy is a component of the Nasdaq CRD Sustainability Index, Bloomberg’s 2020 Gender-Equality Index, and the S&P 500. For more information, visit alliantenergy.com and follow us on LinkedIn, Facebook, Instagram and Twitter

Media Contact: Scott Reigstad (608) 458-3145

Investor Relations Contact: Susan Gille (608) 458-3956



Aerovate Therapeutics Appoints Timothy Noyes as Chief Executive Officer

BOSTON, May 18, 2021 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Aerovate), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced the appointment of veteran biotechnology leader Timothy Noyes as Chief Executive Officer. Mr. Noyes was also elected to the Aerovate Board of Directors in April 2021.

“Tim is an incredible leader with deep experience in drug development, commercialization and company building. We are excited to welcome him to Aerovate as we look to advance our novel inhaled aerosol drug candidate into efficacy trials for the treatment of pulmonary arterial hypertension, also known as PAH,” said Benjamin Dake, PhD, Founder and President of Aerovate.

Mr. Noyes is an accomplished executive with 30 years of experience leading all aspects of research, development and commercialization in the biopharmaceutical industry. Mr. Noyes previously was President and CEO of Proteon Therapeutics, where he built a team that successfully advanced an innovative biologic for blood vessel remodeling from pre-clinical development through Phase 3 clinical trials. Mr. Noyes was Chief Operating Officer of Trine Pharmaceuticals and held the position of President of Genzyme’s Renal Division following Genzyme’s acquisition of GelTex Pharmaceuticals, where he had held various senior leadership roles. Mr. Noyes began his career at Merck & Co., serving in commercial roles in the company’s cardiovascular, gastrointestinal, and managed care divisions. Mr. Noyes received a BA from Harvard College and an MBA from Harvard Business School.

“I am excited to join the team as we work to advance a potentially meaningful therapy for people living with PAH,” said Mr. Noyes. “PAH can negatively impact nearly every aspect of a person’s life, and we are committed to developing our lead drug candidate, AV-101, to determine whether it is safe and effective and could potentially provide patients with a new treatment alternative.”

AV-101 is a dry powder inhaled formulation of the drug imatinib that is designed to deliver the drug directly to diseased lung tissues while limiting systemic exposure. This drug candidate is intended to address the core proliferative disease processes of PAH.

About Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension (PAH) is a rare, progressive proliferative disease of the pulmonary vasculature that affects approximately 70,000 people in the United States and Europe. The disease is characterized by remodeling, constriction and occlusion of the small pulmonary arteries resulting in elevated blood pressure in the pulmonary circulation. PAH causes significant strain on the heart, leading to limitation of physical activity, heart failure and reduced life expectancy despite the current standard of care vasodilator therapies, which dilate pulmonary vessels but do not directly modify the disease. It is estimated that the combined global sales for PAH products in 2020 was $5.4 billion.

About Aerovate Therapeutics, Inc.

Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate’s initial focus is on advancing AV-101, its dry powder inhaled formulation of the drug imatinib for the treatment of PAH. AV-101, delivered using a dry powder inhaler, is designed to deliver the drug directly to diseased lung tissues while limiting systemic exposure. Imatinib demonstrated statistically significant and clinically meaningful benefit in PAH patients in a global Phase 3 trial conducted by Novartis when administered orally as a tablet, but was poorly tolerated due to systemic adverse events and was never approved for PAH. Aerovate has completed a Phase 1 study in healthy volunteers and AV-101 was generally well-tolerated with no serious adverse events reported. For more information, please visit www.aerovatetx.com.

Media contact:

Julio Cantre
[email protected]
202.930.4762 

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8ef8d64a-1afc-40de-b269-ee9f4d2d8bf3



Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of Major Depressive Disorder

Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of Major Depressive Disorder

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that the Institutional Review Board (“IRB”) at the University of the West Indies Hospital, in Jamaica has granted approval to commence the study of its sublingual psilocybin formulation (“CYB001”) in a Phase II clinical trial for patients suffering with Major Depressive Disorder (“MDD”). Commencement of the clinical trial is subject to final confirmation of study material specifications by Jamaica’s Ministry of Health.

MDD is a disease that affected over 7.1% of the U.S. adult population in 2017 according to the National Institute of Mental Health. Globally, nearly 300 million people suffer from depression according to the World Health Organization.

Psilocybin has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration to multiple entities in the USA, and this specific trial will become the first of its kind comparing a 25mg psilocybin capsule with Cybin’s proprietary sublingual film formulation.

The clinical trial will consist of a Phase IIa study of 40 patients to identify the bio-equivalent dose of Cybin’s proprietary sublingual psilocybin formulation versus a 25mg oral capsule. Sublingual delivery is designed to enable rapid absorption of molecules into the bloodstream via the mouth, rather than utilizing the gastrointestinal tract. The goal of the trial is to demonstrate the potential benefits of Cybin’s sublingual delivery method which seeks to deliver faster onset of action, shorter treatment duration, and a lower effective dose.

“IRB approval for our study protocols is an important step forward to begin testing our proprietary psilocybin formulation delivered via absorption under the tongue in patients with Major Depressive Disorder. We are planning several additional studies to expand our clinical understanding of this potentially ground-breaking therapeutic. Cybin continues to expand on its 4 active drug programs targeting depression, addiction and other psychiatric conditions alongside its growing portfolio of 50+ proprietary psychedelic molecules. This latest IRB approval moves Cybin closer to unlocking the potential of more scalable therapeutics,” stated Doug Drysdale, Chief Executive Officer.

Upon successful completion of the Phase IIa study, Cybin plans to study the safety and efficacy of its CYB001 psilocybin drug candidate in a randomized, placebo-controlled Phase IIb study, in 120 patients with MDD. The primary endpoint of this study is expected to be a reduction in the Montgomery-Asberg Depression Rating Scale (“MADRS”) of depression symptoms at 30 days.

The clinical trial will adhere to ICH-GCP (“The International Conference on Harmonization-Good Clinical Practice”) guidelines, with the aim to utilize clinical data across the world in jurisdictions such as the United States, Canada and Europe.

About Cybin

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics for mental illness and addiction by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.

Cautionary Notes and Forward-Looking Statements

Certain statements in this news release related to the Company are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release may include statements regarding enhanced liquidity, the value of additional capital markets exposure, access to institutional and retail investors, the Company’s new strategic brand messaging campaign, and psychedelic drug development programs to potentially treat mental health disorders. There are numerous risks and uncertainties that could cause actual results and Cybin’s plans and objectives to differ materially from those expressed in the forward-looking information. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.

Cybin makes no medical, treatment or health benefit claims about Cybin’s proposed products. The U.S. Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated claims regarding psilocybin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds or nutraceutical products. The efficacy of such products has not been confirmed by approved research. There is no assurance that the use of psilocybin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds or nutraceuticals can diagnose, treat, cure or prevent any disease or condition. Vigorous scientific research and clinical trials are needed. Cybin has not conducted clinical trials for the use of its proposed products. Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials. If Cybin cannot obtain the approvals or research necessary to commercialize its business, it may have a material adverse effect on Cybin’s performance and operations.

The NEO Exchange has neither approved nor disapproved the contents of this news release and is not responsible for the adequacy and accuracy of the contents herein.

Investor Contacts:

Tim Regan/Scott Eckstein

KCSA Strategic Communications

[email protected]

Lisa M. Wilson

In-Site Communications, Inc.

[email protected]

Media Contacts:

John Kanakis

Cybin Inc.

[email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Biotechnology Mental Health Health Pharmaceutical Clinical Trials

MEDIA:

Logo
Logo

Performance Food Group Company to Acquire Core-Mark

Performance Food Group Company to Acquire Core-Mark

  •  Acquisition expands PFG’s geographic reach and market diversification into the growing convenience store channel, adding approximately $17 billion to net sales, resulting in total PFG pro-forma LTM net sales of approximately $44 billion
  • Adds a complementary customer-centric operating model with consistent go-to-market selling cultures focused on customer service
  • Enhances attractive customer base and product offerings, building upon the company’s current foodservice focus within the convenience channel
  • Expected to be accretive to Adjusted Diluted Earnings Per Share (EPS) in the first full fiscal year following closing of the transaction, excluding expected cost synergies
  • Expected to generate approximately $40 million of annual net cost synergies, achieved by the thirdfull year following the closing of the transaction

RICHMOND, Va. & WESTLAKE, Texas–(BUSINESS WIRE)–
Performance Food Group Company (PFG) (NYSE: PFGC) and Core-Mark Holding Company, Inc. (Core-Mark) (NASDAQ: CORE) today announced that they have entered into a definitive agreement pursuant to which PFG will acquire Core-Mark in a stock and cash transaction.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210518005391/en/

Under the terms of the transaction, which has been unanimously approved by the Board of Directors of each company, Core-Mark shareholders will receive $23.875 per share in cash and 0.44 PFG shares for each Core-Mark share. The transaction values Core-Mark at approximately $2.5 billion, including Core-Mark’s net debt. Upon closing of the transaction, Core-Mark shareholders will own approximately 13% of the combined company. Core-Mark expects to continue paying its current quarterly dividend through the completion of the transaction.

The transaction will create a best-in-class convenience business within PFG’s Vistar segment that will include the Core-Mark and Eby-Brown businesses. The expanded convenience business will operate under the Core-Mark brand and will be headquartered in Westlake, Texas with Eby-Brown maintaining ongoing operations in Naperville, Illinois. Scott McPherson will continue in his role as President and Chief Executive Officer of Core-Mark, following closing of the transaction. Tom Wake will continue as President and Chief Executive Officer of Eby-Brown, reporting to Mr. McPherson.

“We are excited to announce the strategic acquisition of Core-Mark and welcome the organization to Performance Food Group,” said George Holm, PFG Chairman, President & Chief Executive Officer. “Core-Mark is an outstanding company that we believe will significantly strengthen our business diversification and expansion into the convenience store channel. Core-Mark brings a highly skilled and experienced workforce along with an experienced senior leadership team, which will be valuable additions to the PFG family of companies. This transaction will also combine Core-Mark’s footprint and operational excellence with PFG’s existing capabilities in both convenience and foodservice. The deal comes with strong strategic and financial merits which we believe will generate significant customer benefits and help PFG continue to create long term shareholder value. The two organizations have similar cultures, which we expect will facilitate a smooth integration and transition process. We look forward to getting to know the associates at Core-Mark better and building a strong future as one organization.”

“On behalf of PFG’s Vistar segment, I echo George’s enthusiasm for this transaction,” said Patrick Hagerty, Executive Vice President of PFG and Chief Executive Officer of Vistar. “Adding convenience store distribution in 2019 built up the core strength of our organization, providing another important avenue for growth. Bringing Core-Mark to PFG will continue this journey and complement our existing portfolio. I look forward to us bringing together the best talent in convenience and welcoming Core-Mark associates at close.”

Core-Mark is one of the largest wholesale distributors to the convenience retail industry in North America with approximately $17 billion in net sales. The company has approximately 7,500 employees and operates 32 distribution centers across the United States and Canada. Core-Mark services approximately 40,000 customer locations in all 50 states in the U.S., five Canadian provinces and two Canadian territories.

“This transaction brings together two companies known for their customer-focused approach and dedication to their employees,” said Scott McPherson, Core-Mark President and Chief Executive Officer. “As part of our continuous focus to maximize shareholder value and better serve our customers, our Board evaluated the transaction and determined this combination provides our investors immediate value and the opportunity to participate in the upside potential of being part of a larger, diversified and customer-centric supplier in the foodservice and convenience retail industry. The combination of our two highly complementary businesses creates an even stronger platform to drive growth, as we deliver a best-in-class offering to our customers. I’d like to thank the entire Core-Mark team for their hard work and focus in helping us reach this exciting milestone.”

Upon closing of the transaction, at least one current Core-Mark director will be added to the PFG Board of Directors.

Compelling Strategic and Financial Benefits

  • Accelerates PFG’s diversification and adds highly complementary assets in the convenience store channel: With the closing of this transaction, PFG will add approximately $17 billion of net sales, resulting in total PFG pro-forma LTM net sales of approximately $44 billion.
  • Adds complementary customer-centric operating model: Core-Mark brings a consistent go-to-market approach with a selling culture focused on customer success.
  • Enhances attractive customer base and product offerings: The transaction builds upon PFG’s current foodservice focus within the convenience channel adding additional customers and product offerings, particularly in the fresh food space.
  • Strong strategic and financial merits: The transaction is expected to be accretive to Adjusted Diluted EPS in the first full fiscal year following the close. The accretion calculation does not include any of the expected cost synergies.
  • Annual run-rate net cost synergies of approximately $40 million expected to be achieved by the third full year after closing.

Transaction Financing

The transaction is not conditioned on financing. PFG expects to fund the cash portion of the transaction consideration with borrowing from its asset-based revolving credit facility and the issuance of new senior unsecured notes.

Timing and Approvals

The transaction is expected to close in the first half of calendar 2022, subject to U.S. federal antitrust clearance, Core-Mark shareholder approval, and other customary closing conditions. The transaction is not subject to PFG shareholder approval.

Advisors

BMO Capital Markets Corp. acted as the exclusive financial advisor to PFG, and J.P. Morgan Securities LLC provided a fairness opinion to the Board of Directors of PFG. Skadden, Arps, Slate, Meagher & Flom LLP acted as legal counsel to PFG. Barclays acted as the exclusive financial advisor to Core-Mark. Weil, Gotshal & Manges LLP acted as legal counsel to Core-Mark.

Conference Call and Webcast Information

Performance Food Group will host a webcast and conference call at 9:00 AM Eastern Time today, May 18, to discuss the transaction. The live audio webcast and presentation slides will be available on http://investors.pfgc.com/ under Events & Presentations. The conference call may be accessed by Conference ID: 8235877

Participant Toll Free Dial-In Number: (877) 569-1666

Participant International Dial-In Number: (919) 666-6542

Please dial in 10 to 15 minutes prior to the call start time. Following the Company’s remarks, the conference call will include a question-and-answer session with the investment community. A digital recording of the conference call will be available for replay two hours after the call’s completion. To access the recording, please use one of the following Dial-In Numbers and the Conference ID shown above.

Participant Replay Toll Free Dial-In Number: (855) 859-2056

Participant Replay International Dial-In Number: (404) 537-3406

About Performance Food Group Company

Built on the many proud histories of our family of companies, Performance Food Group is a customer-centric foodservice distribution leader headquartered in Richmond, Virginia. Grounded by roots that date back to a grocery peddler in 1885, PFG today has a nationwide network of over 100 distribution facilities, thousands of talented associates and valued suppliers across the country. With the goal of helping our customers thrive, we market and deliver quality food and related products to over 200,000 locations including independent and chain restaurants, schools, business and industry locations, healthcare facilities, vending distributors, office coffee service distributors, big box retailers, theaters and convenience stores. Building strong relationships is core to PFG’s success – from connecting associates with great career opportunities to connecting valued suppliers and quality products with PFG’s broad and diverse customer base. To learn more about PFG, visit pfgc.com.

About Core-Mark

Core-Mark is one of the largest marketers of fresh, food and broad-line supply solutions to the convenience retail industry in North America. Founded in 1888, Core-Mark offers a full range of products, marketing programs and technology solutions to approximately 40,000 customer locations in the U.S. and Canada through 32 distribution centers (excluding two distribution facilities the Company operates as a third-party logistics provider). Core-Mark services traditional convenience stores, grocers, drug stores, mass merchants, liquor and specialty stores, and other stores that carry convenience products. For more information, please visit www.core-mark.com.

Forward-Looking Statements

This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, statements related to our expectations regarding the performance of PFG and Core-Mark’s respective business, financial results, liquidity and capital resources, and other non-historical statements. You can identify these forward-looking statements by the use of words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “projects,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words.

Such forward-looking statements are subject to various risks and uncertainties. The following factors, in addition to those discussed under the section entitled Item 1A. Risk Factors in the PFG Annual Report on Form 10-K for the fiscal year ended June 27, 2020 filed with the Securities and Exchange Commission (the “SEC”) on August 18, 2020, and the section entitled Item 1A. Risk Factors the Core-Mark Annual Report on Form 10-K for the fiscal year ended December 31, 2020 filed with the SEC on March 1, 2021, as such factors may be updated from time to time in our respective periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov, could cause actual future results to differ materially from those expressed in any forward-looking statements:

  • the integration of PFG’s acquisition of Reinhart;
  • the material adverse impact the COVID-19 pandemic has had and is expected to continue to have on the global markets, the restaurant industry and the convenience retail industry, and PFG and Core-Mark’s businesses specifically, including the effects on vehicle miles driven, on the financial health of PFG and Core-Mark’s business partners, on supply chains, and on financial and capital markets;
  • competition in PFG and Core-Mark’s industries is intense, and PFG or Core-Mark may not be able to compete successfully;
  • PFG and Core-Mark operates in low margin industries, which could increase the volatility of their respective results of operations;
  • PFG may not realize anticipated benefits from operating cost reduction and productivity improvement efforts;
  • PFG’s profitability is directly affected by cost inflation and deflation and other factors;
  • PFG does not have long-term contracts with certain of customers;
  • group purchasing organizations may become more active in PFG’s industry and increase their efforts to add customers as members of these organizations;
  • changes in eating habits of consumers;
  • extreme weather conditionsincluding earthquake and natural disaster damage;
  • reliance on third-party suppliers, including Core-Mark’s reliance on relatively few suppliers;
  • labor relations and cost risks and availability of qualified labor;
  • volatility of fuel and other transportation costs;
  • inability to adjust cost structure where one or more of competitors successfully implement lower costs;
  • PFG may be unable to increase sales in the highest margin portion of its business;
  • changes in pricing practices of suppliers;
  • PFG or Core-Mark’s growth strategy may not achieve the anticipated results;
  • risks relating to acquisitions, including the risk that PFG is not able to realize benefits of acquisitions or successfully integrate the businesses PFG acquires;
  • environmental, health, and safety costs;
  • the risk that PFG or Core-Mark fails to comply with requirements imposed by applicable law or government regulations or substantial changes to governmental regulations, including increased regulation of electronic cigarette and other alternative nicotine products;
  • a portion of PFG and Core-Mark’s sales volume is dependent upon the distribution of cigarettes and other tobacco products, sales of which are generally declining;
  • if the products PFG distributes are alleged to cause injury or illness or fail to comply with governmental regulations, and PFG may need to recall products and may experience product liability claims;
  • PFG’s reliance on technology and risks associated with disruption or delay in implementation of new technology;
  • costs and risks associated with a potential cybersecurity incident or other technology disruption;
  • product liability claims relating to the products distributed by PFG or Core-Mark, including litigation related to Juul products and other litigation;
  • adverse judgements or settlementsor unexpected outcomes in legal proceedings;
  • negative media exposure and other events that damage PFG or Core-Mark’s reputation;
  • decrease in earnings from amortization charges associated with acquisitions;
  • impact of uncollectibility of accounts receivable;
  • difficult economic conditions affecting consumer confidence;
  • risks relating to federal, state, and local tax rules and changes to federal, state or provincial income tax legislation;
  • increases in excise taxes or reduction in credit terms by taxing jurisdictions;
  • the cost and adequacy of insurance coverage and increases in the number or severity of insurance and claims expenses;
  • risks relating to PFG or Core-Mark’s outstanding indebtedness;
  • PFG or Core-Mark’s ability to raise additional capital;
  • PFG or Core-Mark’s ability to maintain an effective system of disclosure controls and internal control over financial reporting;
  • Core-Mark’s dependence on the convenience retail industry for revenues;
  • Core-Mark’s dependence on qualified labor, senior management and other key personnel;
  • competition in Core-Mark’s distribution markets, including product, service and pricing pressures related to COVID-19;
  • the dependence of some of Core-Mark’s distribution centers on a few relatively large customers;
  • manufacturers or retail customers adopting direct distribution channels;
  • failure, disruptions or security breaches of Core-Mark’s information technology systems;
  • Core-Mark’s reliance on manufacturer discount and incentive programs and cigarette excise stamping allowances;
  • disruptions in suppliers’ operations, including the impact of COVID-19 on Core-Mark’s suppliers as well as supply chain, including potential problems with inventory availability and the potential result of higher cost of product and freight due to high demand of products and low supply for an unpredictable period of time;
  • Core-Mark’s ability to achieve the expected benefits of implementation of marketing initiatives;
  • failure to maintain PFG or Core-Mark’s brand and reputation;
  • attempts by unions to organize employees;
  • increasing expenses related to employee health benefits;
  • changes to minimum wage laws;
  • risks related to changes to Core-Mark’s workforce, including reductions to hours, headcount and benefits as a result of COVID-19;
  • legislation, regulations and other matters negatively affecting the cigarette, tobacco and alternative nicotine industry;
  • potential liabilities associated with sales of cigarettes and other tobacco products;
  • reduction in the payment of dividends;
  • currency exchange rate fluctuations;
  • Core-Mark ability to borrow additional capital;
  • restrictive covenants in Core-Mark’s credit facility;
  • changes to accounting rules or regulations; and
  • the following risks related to the proposed acquisition of Core-Mark ( the “Core-Mark Transaction”):

o the risk that U.S. federal antitrust clearance or other approvals required for the Core-Mark Transaction may be delayed or not obtained or are obtained subject to conditions that are not anticipated that could require the exertion of PFG or Core-Mark’s respective management’s time and resources or otherwise have an adverse effect on PFG or Core-Mark;

o the possibility that conditions to the consummation of the Core-Mark Transaction, including approval by Core-Mark stockholders, will not be satisfied or completed on a timely basis and accordingly the Core-Mark Transaction may not be consummated on a timely basis or at all;

o uncertainty as to the expected Core-Mark performance of the combined company following completion of the Core-Mark Transaction;

o the possibility that the expected synergies and value creation from the Core-Mark Transaction will not be realized or will not be realized within the expected time period;

o the exertion of PFG or Core-Mark’s respective management’s time and resources, and other expenses incurred and business changes required, in connection with complying with the undertakings in connection with U.S. federal antitrust clearance or other third-party consents or approvals for the Core-Mark Transaction;

o the risk that unexpected costs will be incurred in connection with the completion and/or integration of the Core-Mark Transaction or that the integration of Core-Mark will be more difficult or time consuming than expected;

o availability of debt financing for the Core-Mark Transaction and PFG’s refinancing plans on terms that are favorable to PFG;

o a downgrade of the credit ratings of PFG or Core-Mark’s indebtedness, which could give rise to an obligation to redeem existing indebtedness;

o potential litigation in connection with the Core-Mark Transaction may affect the timing or occurrence of the Core-Mark Transaction or result in significant costs of defense, indemnification and liability;

o the inability to retain key personnel;

o the possibility that competing offers will be made to acquire Core-Mark;

o disruption from the announcement, pendency and/or completion of the Core-Mark Transaction, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; and

o the risk that, following the Core-Mark Transaction, the combined company may not be able to effectively manage its expanded operations.

Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in PFG’s and Core-Mark’s filings with the SEC. Any forward-looking statement, including any contained herein, speaks only as of the time of this release or as of the date they were made and neither PFG nor Core-Mark undertake to update or revise them as more information becomes available or to disclose any facts, events, or circumstances after the date of this release, as applicable, that may affect the accuracy of any forward-looking statement, except as required by law.

Important Additional Information and Where to Find It

In connection with the proposed transaction, PFG intends to file with the SEC a registration statement on Form S-4 (the “Registration Statement”), which will include a prospectus with respect to the shares of PFG’s common stock to be issued in the proposed transaction and a proxy statement for Core-Mark’s stockholders (the “Proxy Statement”). Core-Mark will send the Proxy Statement to its stockholders, and each party may file other documents regarding the proposed transaction with the SEC. This communication is not a substitute for the Form S-4, the Proxy Statement or any other document that Core-Mark may send to its stockholders in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF PFG AND CORE-MARK ARE URGED TO READ THE FORM S-4, THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) THAT WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT PFG, CORE-MARK, THE PROPOSED TRANSACTION AND RELATED MATTERS. Investors and security holders of PFG and Core-Mark will be able to obtain free copies of the Form S-4, the Proxy Statement and other documents (including any amendments or supplements thereto) containing important information about PFG and Core-Mark once those documents are filed with the SEC, through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with the SEC by PFG will be available free of charge on PFG’s website at www.investors.pfgc.com or by contacting PFG’s Investor Relations department at [email protected]. Copies of the documents filed with the SEC by Core-Mark will be available free of charge on Core-Mark’s website at ir.core-mark.com/investors or by contacting Core-Mark’s Investor Relations department at [email protected].

Participants In The Solicitation

PFG, Core-Mark and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies from the stockholders of Core-Mark in connection with the proposed transaction.

Information about the directors and executive officers of PFG is set forth in its (i) Form 10-K for the fiscal year ended June 27, 2020, which was filed with the SEC on August 18, 2020 and (ii) proxy statement for its 2020 annual meeting of stockholders, which was filed with the SEC on October 9, 2020, and on its website at www.pfgc.com.

Information about the directors and executive officers of Core-Mark is set forth in its (i) Form 10-K for the fiscal year ended December 31, 2020, which was filed with the SEC on March 1, 2021 and (ii) proxy statement for its 2021 annual meeting of stockholders, which was filed with the SEC on April 5, 2021, and on its website at www.core-mark.com.

Investors may obtain additional information regarding the interest of such participants by reading the Form S-4, the Proxy Statement and other materials to be filed with the SEC in connection with proposed transaction when they become available.

No Offer or Solicitation

This communication is for informational purposes only and does not constitute, or form a part of, an offer to sell or the solicitation of an offer to sell or an offer to buy or the solicitation of an offer to buy any securities, and there shall be no sale of securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.

PFG Investors:

Bill Marshall

VP, Investor Relations

(804) 287-8108

[email protected]

PFG Media:

Trisha Meade

Director, Communications & Engagement

(804) 285-5390

[email protected]

Core-Mark Investors:

David Lawrence

VP, Treasury & Investor Relations

(800) 622-1713 x 7923

[email protected]

Core-Mark Media:

Aaron Palash / Jack Kelleher

Joele Frank, Wilkinson Brimmer Katcher

(212) 355-4449

KEYWORDS: United States North America Texas Virginia

INDUSTRY KEYWORDS: Discount/Variety Trucking Transport Supermarket Convenience Store Restaurant/Bar Food/Beverage Logistics/Supply Chain Management Supply Chain Management Retail

MEDIA:

Logo
Logo
Logo
Logo

Owens Corning Earns No. 1 Ranking on 100 Best Corporate Citizens List for an Unprecedented Third Year in a Row

Owens Corning Earns No. 1 Ranking on 100 Best Corporate Citizens List for an Unprecedented Third Year in a Row

TOLEDO, Ohio–(BUSINESS WIRE)–
Owens Corning (NYSE: OC) earned the top spot on the 100 Best Corporate Citizens list for 2021, announced today by 3BL Media. The company was also No. 1 in 2020 and 2019, making it the first to earn the top ranking for three consecutive years.

“Earning the top honor for a third year in a row demonstrates our commitment to doing more,” said Chairman and Chief Executive Officer Brian Chambers. “An achievement like this isn’t the product of any individual team or business. It reflects the efforts of all 19,000 of our employees working together every day to do more for our customers and our world.”

The annual 100 Best Corporate Citizens list recognizes outstanding environmental, social and governance (ESG) transparency and performance among the 1,000 largest, publicly traded U.S. companies.

“At Owens Corning, we are driven to make the world a better place – and our sustainability aspirations reflect that drive,” said Senior Vice President and Chief Sustainability Officer Frank O’Brien-Bernini. “We know we can make a difference through our work, and being placed at the top of the 100 Best Corporate Citizens list illustrates the tangible impact of integrating sustainability and ESG into our business. This recognition inspires us to go further faster, in all forms of collaborations, to shape the future we desire.”

The 2021 ranking is based on 146 factors spanning eight pillar categories: employees, environment, climate change, stakeholders and society, human rights, ESG performance, governance, and financial. Owens Corning ranked first among all companies in three categories (climate change, human rights, and ESG performance) and placed among the top five in all but three of the eight categories. The list ranks companies in the Russell 1000 Index based upon research by ISS ESG, the responsible investment research arm of Institutional Shareholder Services. Information for the ranking is compiled exclusively from publicly available resources and companies do not pay for the assessment.

Details about how Owens Corning operates, as well as its sustainability commitments and progress, can be found in the company’s 2020 Sustainability Report, which was released in April 2021.

For access to the complete 100 Best Corporate Citizens of 2021 list, please visit 100best.3blmedia.com.

About Owens Corning

Owens Corning is a global building and industrial materials leader. The company’s three integrated businesses are dedicated to the manufacture and advancement of a broad range of insulation, roofing and fiberglass composite materials. Leveraging the talents of 19,000 employees in 33 countries, Owens Corning provides innovative products and sustainable solutions that address energy efficiency, product safety, renewable energy, durable infrastructure, and labor productivity. These solutions provide a material difference to the company’s customers and make the world a better place. Based in Toledo, Ohio, USA, the company posted 2020 sales of $7.1 billion. Founded in 1938, it has been a Fortune 500® company for 66 consecutive years. For more information, please visit www.owenscorning.com.

Owens Corning Company News / Owens Corning Investor Relations News

Media Inquiries:

Todd Romain

419.248.7826

Investor Inquiries:

Amber Wohlfarth

419.248.5639

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Residential Building & Real Estate Manufacturing Commercial Building & Real Estate Construction & Property Building Systems Other Manufacturing

MEDIA: